No data to show
OTCM
ETAOF
Market cap0kUSD
Feb 20, Last price
0.00USD
Name
ETAO International Co Ltd
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
58m
+8.85%
Net income
-897m
L+8,404.67%
CFO
11m
P
Profile
ETAO International Co., Ltd., a digital healthcare company, provides medical care and biomedical technologies to patients in China. It is involved in designing an ecosystem that consist of hospitals, specialized clinics, artificial intelligence/big data diagnosis, medical analysis services, biotechnology companies, and an insurance agency company that enables patient to receive medical assistance and healthcare services. The company is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||
Revenues | 58,060 8.85% | ||
Cost of revenue | 795,206 | ||
Unusual Expense (Income) | |||
NOPBT | (737,146) | ||
NOPBT Margin | |||
Operating Taxes | 657 | ||
Tax Rate | |||
NOPAT | (737,803) | ||
Net income | (896,678) 8,404.67% | ||
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | 616 | ||
BB yield | -0.06% | ||
| Debt | |||
Debt current | 10,065 | ||
Long-term debt | 12,777 | ||
Deferred revenue | |||
Other long-term liabilities | 19,179 | ||
Net debt | 9,430 | ||
| Cash flow | |||
Cash from operating activities | 10,824 | ||
CAPEX | (634) | ||
Cash from investing activities | (3,572) | ||
Cash from financing activities | (2,561) | ||
FCF | (706,360) | ||
| Balance | |||
Cash | 11,834 | ||
Long term investments | 1,578 | ||
Excess cash | 10,509 | ||
Stockholders' equity | (899,007) | ||
Invested Capital | 926,009 | ||
ROIC | |||
ROCE | |||
| EV | |||
Common stock shares outstanding | 5,000 | ||
Price | 202.60 1.91% | ||
Market cap | 1,013,000 1.91% | ||
EV | 1,032,049 | ||
EBITDA | (735,194) | ||
EV/EBITDA | |||
Interest | 504 | ||
Interest/NOPBT | |||